Claudia C. Langenberg - Epidemiology

Author Information

Claudia C. Langenberg is affiliated with the MRC Epidemiology Unit at the University of Cambridge, Cambridge, UK. Her research interests primarily focus on genetic epidemiology and the intersections between genetic factors and complex diseases, including cardiovascular diseases, respiratory conditions, and metabolic disorders.

Research Contributions

In 2022, Claudia C. Langenberg has contributed significantly to the field of epidemiology with multiple high-impact publications. Her research spans various domains, including genome-wide studies on genetic factors associated with circulating uromodulin, genetic architectures of asthma and chronic obstructive pulmonary disease overlap, and the genetic landscape of the ACE2 coronavirus receptor. She has also explored the causal effects of maternal circulating amino acids on offspring birthweight, and identified novel protein biomarkers and drug targets for primary prevention of heart failure. Her work on the clinical characteristics and inflammation profiling of long COVID is also noteworthy.

Aliases

Claudia C. Langenberg is also known by various aliases, including C Langenberg, C. Langenberg, and Claudia Langenberg.

Publication and Citation Metrics

Metric	Value
Citation Count	74,879
h-index	123
Paper Count	554

Publications:

Genome-wide studies reveal factors associated with circulating uromodulin and its relations with complex diseases.

DOI: 10.1172/jci.insight.157035

Year: 2022

An atlas of genetic scores to predict multi-omic traits

DOI: 10.1101/2022.04.17.488593

Year: 2022

Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap.

DOI: 10.1016/j.chest.2021.12.674

Year: 2022

A Saturated Map of Common Genetic Variants Associated with Human Height from 5.4 Million Individuals of Diverse Ancestries

DOI: 10.1101/2022.01.07.475305

Year: 2022

Causal effects of maternal circulating amino acids on offspring birthweight: a Mendelian randomisation study

DOI: 10.1101/2022.04.15.22273911

Year: 2022

Genome-wide association analysis and Mendelian randomization proteomics identify novel protein biomarkers and drug targets for primary prevention of heart failure

DOI: 10.1101/2022.04.14.22273877

Year: 2022

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

DOI: 10.1016/S2213-2600(22)00127-8

Year: 2022

Genetic Landscape of the ACE2 Coronavirus Receptor.

DOI: 10.1161/CIRCULATIONAHA.121.057888

Year: 2022

Genetic Associations and Architecture of Asthma-COPD Overlap

DOI:

Year: 2022

Physical activity attenuates but does not eliminate coronary heart disease risk amongst adults with risk factors: EPIC-CVD case-cohort study.

DOI: 10.1093/eurjpc/zwac055

Year: 2022

Why is External Validity Important in Epidemiology?

What are the Implications of Increased Risk of Infection?

What are the Applications of GAMs in Epidemiology?

What Strategies Are Used to Combat AMR?

Why are Pap Smears Important in Epidemiology?

Why is Broad Coverage Important?

How is Descriptive Data Collected?

How Do Environmental Factors Affect Population Health?

Why is Patient Diversity Important in Epidemiology?

What are Multiplex Assays?

Partnered Content Networks

Relevant Topics